Registration
HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP) for BOEHRINGER INGELHEM PHARAMACEUTICALS INC
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Compounding pharmacy legislation, drug safety, drug patents, federal health care spending.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M. CLAPTON New | Chief Health Counsel, House Energy/Com ; ; Chief Health Counsel, House Ways/Means ; ; Policy Advisor, Speaker D. Hastert ; ; Health Policy Dir., Senate HELP Cmte. |
Health Issues HCR
Compounding pharmacy legislation, drug safety, drug patents, federal health care spending.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHARLES M. CLAPTON New | Chief Health Counsel, House Energy/Com ; ; Chief Health Counsel, House Ways/Means ; ; Policy Advisor, Speaker D. Hastert ; ; Health Policy Dir., Senate HELP Cmte. |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| BOEHRINGER INGELHEIM GMBH, CORPORATE DIVISION COMMUNICATIONS | Germany | Germany | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.